First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers

$1,066,904ZIAFY2024TRNIH

National Center For Advancing Translational Sciences

Investigators

Sharie Haugabookcontact

View original record on NIH RePORTER →

First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers · GrantIndex